Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells | BMC Biology | Full Text
Epigenetic downregulation of HER2 during EMT leads to tumor resistance to HER2-targeted therapies in breast cancer | bioRxiv
Epigenetic downregulation of HER2 during EMT leads to tumor resistance to HER2-targeted therapies in breast cancer | bioRxiv
T cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors - ScienceDirect
HER2-positive breast cancer - The Lancet
HER2 expression in primary breast cancer tissues. ( A ), Western blot... | Download Scientific Diagram
Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program☆ - ESMO Open
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Cancers | Free Full-Text | Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer
Clinical applications of mouse models for breast cancer engaging HER2/neu
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Cancers | Free Full-Text | HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness
BMS-599626 (AC480), HER1 and HER2 inhibitor (CAS 8173837-23-1) (ab142063)
Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink
Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice | Scientific Reports
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions | Nature Communications
Various epigenetic markers involved in HER2 positive breast cancer.... | Download Scientific Diagram
Figure 1 from STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits | Semantic Scholar
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Frontiers | Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
HER2 - Wikipedia
Cancers | Free Full-Text | Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
